DrugCite
Search

YERVOY

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Yervoy Adverse Events Reported to the FDA Over Time

How are Yervoy adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Yervoy, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Yervoy is flagged as the suspect drug causing the adverse event.

Most Common Yervoy Adverse Events Reported to the FDA

What are the most common Yervoy adverse events reported to the FDA?

Death
206 (7.46%)
Diarrhoea
159 (5.76%)
Neoplasm Malignant
150 (5.43%)
Colitis
65 (2.35%)
Rash
65 (2.35%)
Nausea
56 (2.03%)
Pruritus
51 (1.85%)
Fatigue
49 (1.77%)
Decreased Appetite
35 (1.27%)
Pyrexia
34 (1.23%)
Dehydration
32 (1.16%)
Show More Show More
Headache
32 (1.16%)
Abdominal Pain
31 (1.12%)
Vomiting
30 (1.09%)
Asthenia
24 (.87%)
Constipation
23 (.83%)
Intestinal Perforation
23 (.83%)
Hypotension
22 (.8%)
Dyspnoea
21 (.76%)
Gastrointestinal Haemorrhage
21 (.76%)
Hypophysitis
21 (.76%)
Metastases To Central Nervous Syste...
21 (.76%)
Adverse Event
20 (.72%)
Anaemia
20 (.72%)
General Physical Health Deteriorati...
20 (.72%)
Renal Failure
19 (.69%)
Thrombocytopenia
19 (.69%)
Enterocolitis
18 (.65%)
Hepatic Failure
18 (.65%)
Neuropathy Peripheral
18 (.65%)
Weight Decreased
18 (.65%)
Respiratory Failure
17 (.62%)
Pneumonitis
16 (.58%)
Liver Function Test Abnormal
15 (.54%)
Malaise
15 (.54%)
Pulmonary Embolism
15 (.54%)
Vision Blurred
15 (.54%)
Pain
14 (.51%)
Hyponatraemia
13 (.47%)
Infusion Related Reaction
13 (.47%)
Renal Failure Acute
13 (.47%)
Autoimmune Hepatitis
12 (.43%)
Cerebral Haemorrhage
12 (.43%)
Chest Pain
12 (.43%)
Deep Vein Thrombosis
12 (.43%)
Large Intestine Perforation
12 (.43%)
Muscular Weakness
12 (.43%)
Pneumonia
12 (.43%)
Sepsis
12 (.43%)
Blood Thyroid Stimulating Hormone D...
11 (.4%)
Chills
11 (.4%)
Convulsion
11 (.4%)
Fall
11 (.4%)
Haemoptysis
11 (.4%)
Rash Pruritic
11 (.4%)
Arthralgia
10 (.36%)
Depression
10 (.36%)
Dizziness
10 (.36%)
Erythema
10 (.36%)
Hepatic Enzyme Increased
10 (.36%)
Hypothyroidism
10 (.36%)
Blood Thyroid Stimulating Hormone I...
9 (.33%)
Cough
9 (.33%)
Haemoglobin Decreased
9 (.33%)
Inflammation
9 (.33%)
Oedema
9 (.33%)
Visual Impairment
9 (.33%)
Abdominal Pain Upper
8 (.29%)
Back Pain
8 (.29%)
Blood Bilirubin Increased
8 (.29%)
Gastrointestinal Disorder
8 (.29%)
Haematochezia
8 (.29%)
Hepatomegaly
8 (.29%)
Neutropenia
8 (.29%)
Transaminases Increased
8 (.29%)
Confusional State
7 (.25%)
Dermatitis
7 (.25%)
Hepatotoxicity
7 (.25%)
Herpes Zoster
7 (.25%)
Hypophagia
7 (.25%)
Hypopituitarism
7 (.25%)
Infection
7 (.25%)
Lymphadenopathy
7 (.25%)
Multi-organ Failure
7 (.25%)
Myocardial Infarction
7 (.25%)
Rash Generalised
7 (.25%)
Tachycardia
7 (.25%)
Tremor
7 (.25%)
Urinary Tract Infection
7 (.25%)
Flatulence
6 (.22%)
Haemorrhage
6 (.22%)
Hepatic Encephalopathy
6 (.22%)
Hyperthyroidism
6 (.22%)
Metastases To Liver
6 (.22%)
Musculoskeletal Pain
6 (.22%)
Oedema Peripheral
6 (.22%)
Pancytopenia
6 (.22%)
Pleural Effusion
6 (.22%)
Rash Erythematous
6 (.22%)
Skin Disorder
6 (.22%)
Speech Disorder
6 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Yervoy, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Yervoy is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Yervoy

What are the most common Yervoy adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Yervoy, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Yervoy is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Yervoy According to Those Reporting Adverse Events

Why are people taking Yervoy, according to those reporting adverse events to the FDA?

Malignant Melanoma
328
Metastatic Malignant Melanoma
261
Malignant Melanoma Stage Iv
7
Metastatic Ocular Melanoma
5
Metastases To Liver
4
Metastases To Lung
3
Show More Show More
Prostate Cancer
3
Renal Cancer
2
Metastases To Central Nervous Syste...
2
Choroid Melanoma
2
Metastasis
2
Investigation
1
Skin Cancer
1
Metastatic Neoplasm
1
Melanoma Recurrent
1
Tongue Neoplasm Malignant Stage Uns...
1
Brain Neoplasm
1
Non-small Cell Lung Cancer
1
Intraocular Melanoma
1
Lung Neoplasm
1
Malignant Neoplasm Of Conjunctiva
1

Drug Labels

LabelLabelerEffective
YervoyE.R. Squibb & Sons, L.L.C.20-NOV-12

Yervoy Case Reports

What Yervoy safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Yervoy. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Yervoy.